To investigate whether the therapeutic effects observed in acute models of colitis was maintained over time, Rag1−/− rendered colitic by transfer of CD4+ T cells from wild type donors, were administered with maraviroc 50 mg/kg/d for 3 weeks starting on day 34 after colitis induction. Here, CD4 is linked to colitis.